ImmunityBio, Inc. (IBRX)
7.575
-0.22
(-2.76%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
-0.06
(-0.73%)
After-Hours: 20:00
ImmunityBio Total Liabilities (Quarterly) : 1.674B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.674B |
| March 31, 2026 | 1.516B |
| December 31, 2025 | 1.001B |
| September 30, 2025 | 1.042B |
| June 30, 2025 | 971.90M |
| March 31, 2025 | 894.24M |
| December 31, 2024 | 871.06M |
| September 30, 2024 | 1.109B |
| June 30, 2024 | 1.142B |
| March 31, 2024 | 1.092B |
| December 31, 2023 | 1.090B |
| September 30, 2023 | 843.06M |
| June 30, 2023 | 936.41M |
| March 31, 2023 | 875.12M |
| December 31, 2022 | 812.18M |
| September 30, 2022 | 782.02M |
| June 30, 2022 | 739.69M |
| March 31, 2022 | 727.14M |
| December 31, 2021 | 712.82M |
| September 30, 2021 | 404.36M |
| June 30, 2021 | 404.89M |
| March 31, 2021 | 394.76M |
| December 31, 2020 | 34.46M |
| September 30, 2020 | 31.91M |
| Date | Value |
|---|---|
| June 30, 2020 | 26.51M |
| March 31, 2020 | 24.43M |
| December 31, 2019 | 22.44M |
| September 30, 2019 | 24.25M |
| June 30, 2019 | 24.43M |
| March 31, 2019 | 40.45M |
| December 31, 2018 | 35.94M |
| September 30, 2018 | 39.56M |
| June 30, 2018 | 29.80M |
| March 31, 2018 | 29.48M |
| December 31, 2017 | 31.60M |
| September 30, 2017 | 40.03M |
| June 30, 2017 | 48.70M |
| March 31, 2017 | 25.31M |
| December 31, 2016 | 24.08M |
| September 30, 2016 | 21.52M |
| June 30, 2016 | 15.58M |
| March 31, 2016 | 12.93M |
| December 31, 2015 | 10.85M |
| September 30, 2015 | 7.26M |
| June 30, 2015 | 6.039M |
| March 31, 2015 | 3.055M |
| December 31, 2014 | 2.405M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.661B |
| Cogent Biosciences, Inc. | 302.16M |
| Moderna, Inc. | 4.20B |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 628.50M |
| Shareholders Equity (Quarterly) | -1.047B |
| Debt to Equity Ratio | -1.174 |
| Current Ratio | 5.721 |
| Net Debt Paydown Yield | -0.88% |